Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis
Rui-Rui Peng A , Hong-Min Li A , Helena Chang B , Jian-Hong Li C , Alberta L. Wang D and Xiang-Sheng Chen A E
+ Author Affiliations
- Author Affiliations
A Chinese Academy of Medical Sciences and Peking Union Medical College, Institute of Dermatology, National Center for STD Control, 12 Jiangwangmiao Street, Nanjing 210042, China.
B University of Wisconsin School of Medicine and Public Health, 750 Highland Avenue, Madison, WI 53705, USA.
C Department of Dermatology and Venerology, Dongzhimen Hospital affiliated to Peking University of Chinese Medicine, No. 5 Haiyuncang, Beijing 100700, China.
D University of Texas Medical School at Houston, 6431 Fannin Street, MSB G.400, Houston, TX 77030, USA.
E Corresponding author. Email: chenxs@ncstdlc.org
Sexual Health 9(2) 113-119 https://doi.org/10.1071/SH11066
Submitted: 23 April 2011 Accepted: 6 June 2011 Published: 23 November 2011
Abstract
Cervical human papillomavirus (HPV) infection is highly transmissible. Although there are many studies on HPV infection in general population of women globally, little attention has been paid to female sex workers (FSWs) in Asia. In this study, we used a meta-analytic approach to systematically analyse the literature to elucidate the prevalence and genotype distribution of cervical HPV infection among FSWs in Asia. Fourteen eligible studies were identified in five databases, and data including 4198 FSWs from nine Asian countries were aggregated. Crude estimates of cervical HPV prevalence among FSWs in this region ranged from 12.8% to 84.8%. FSWs had a nearly 10-fold risk of HPV infection than the general population of women. Stratified analysis showed that HPV prevalence was higher in East Asia than other subregions and in younger FSWs than older FSWs. HPV genotype distribution was statistically different between East Asia and South-east Asia. In East Asia, the most prevalent genotypes were HPV 16 (23.9%), 18 (11.0%), 58 (9.4%), 56 (6.3%) and 52 (5.3%), while they were HPV 52 (12.9%), 16 (8.5%), 58 (5.2%), 18 (5.0%) and 66 (4.9%) in South-east Asia. HPV 31, 33 and 35 were less frequently found in both subregions. HPV infection was substantial among FSWs in some Asian countries. More studies are necessary to illustrate the overall picture of HPV infection in this region.
Additional keywords: Asia, female sex workers, genotype, meta-analysis.
References
[1] Ferlay J, Bray F, Pisani P. Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase, No. 5. Version 2.0 Lyon: IARC Press; 2004. Available online at: http://www-dep.iarc.fr/ [accessed February 2011].[2] WHO/ICO Information Centre on HPV and Cervical Cancer. HPV and cervical cancer in the world: 2007 Report. Vaccine 2007; 25 C1–C26.
| 18068032PubMed |
[3] Parkin DM, Louie KS, Clifford G. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region. Vaccine 2008; 26 M1–16.
| Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.Crossref | GoogleScholarGoogle Scholar | 18945410PubMed |
[4] Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55 244–65.
| The causal relation between human papillomavirus and cervical cancer.Crossref | GoogleScholarGoogle Scholar | 11919208PubMed |
[5] Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol 2005; 6 204
| Carcinogenicity of human papillomaviruses.Crossref | GoogleScholarGoogle Scholar | 15830458PubMed |
[6] Lehoux M, D’Abramo CM, Archambault J. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 2009; 12 268–80.
| Molecular mechanisms of human papillomavirus-induced carcinogenesis.Crossref | GoogleScholarGoogle Scholar | 19684440PubMed |
[7] de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324 17–27.
| Classification of papillomaviruses.Crossref | GoogleScholarGoogle Scholar | 15183049PubMed |
[8] de Villiers EM, Whitley C, Gunst K. Identification of new papillomavirus types. Methods Mol Med 2005; 119 1–13.
| 16350392PubMed |
[9] Burk RD, Chen Z, Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics. 2009; 12 281–90.
| Human papillomaviruses: genetic basis of carcinogenicity.Crossref | GoogleScholarGoogle Scholar | 19684441PubMed |
[10] Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348 518–27.
| Epidemiologic classification of human papillomavirus types associated with cervical cancer.Crossref | GoogleScholarGoogle Scholar | 12571259PubMed |
[11] Bogaards JA, Xiridou M, Coupe VM, Meijer CJ, Wallinga J, Berkhof J. Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. Am J Epidemiol 2010; 171 817–25.
| Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus.Crossref | GoogleScholarGoogle Scholar | 20231211PubMed |
[12] Javanbakht M, Gorbach PM, Amani B, Walker S, Cranston RD, Datta SD, et al Concurrency, sex partner risk, and high-risk human papillomavirus infection among African American, Asian, and Hispanic women. Sex Transm Dis 2010; 37 68–74.
| Concurrency, sex partner risk, and high-risk human papillomavirus infection among African American, Asian, and Hispanic women.Crossref | GoogleScholarGoogle Scholar | 19823110PubMed |
[13] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 e1000097
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Crossref | GoogleScholarGoogle Scholar | 19621072PubMed |
[14] Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6 e1000100
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.Crossref | GoogleScholarGoogle Scholar | 19621070PubMed |
[15] Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005; 14 1157–64.
| Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.Crossref | GoogleScholarGoogle Scholar | 15894666PubMed |
[16] Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121 621–32.
| Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.Crossref | GoogleScholarGoogle Scholar | 17405118PubMed |
[17] Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, editors. Publication bias. In: Introduction to Meta-analysis, 1st edition. Chichester: Wiley; 2009; 277–91.
[18] Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327 557–60.
| Measuring inconsistency in meta-analyses.Crossref | GoogleScholarGoogle Scholar | 12958120PubMed |
[19] Ngan HY, Collins RJ, Wong KY, Cheung A, Lai CF, Liu YT. Cervical human papilloma virus infection of women attending social hygiene clinics in Hong Kong. Int J Gynaecol Obstet 1993; 41 75–9.
| Cervical human papilloma virus infection of women attending social hygiene clinics in Hong Kong.Crossref | GoogleScholarGoogle Scholar | 8098299PubMed |
[20] Yang F, Li YS, Zhou H, Wu ZH. Detection of sexually transmitted infections among detained female commercial sex workers by fluorescent quantitative PCR assay in Shenzhen. Chin J Lepr Skin Dis. 2004; 20 334–5.
[21] Jia HQ. Epidemiological investigation of HPV prevalence and incidence rates of cervical cancer and CIN on entertainment female sex workers. Available online at: http://www.lunwenchina.net.cn/buypaper/fkx/50997.html [accessed October 2010].
[22] Ishi K, Suzuki F, Saito A, Kubota T. Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan. J Obstet Gynaecol Res 2000; 26 253–7.
| Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan.Crossref | GoogleScholarGoogle Scholar | 11049234PubMed |
[23] Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS. Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol 2003; 71 440–5.
| Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers.Crossref | GoogleScholarGoogle Scholar | 12966552PubMed |
[24] Yun H, Park J, Choi I, Kee M, Choi B, Kim S. Prevalence of human papillomavirus and herpes simplex virus type 2 infection in Korean commercial sex workers. J Microbiol Biotechnol 2008; 18 350–4.
| 18309283PubMed |
[25] Thomas DB, Ray RM, Kuypers J, Kiviat N, Koetsawang A, Ashley RL, et al Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. Am J Epidemiol 2001; 153 740–8.
| Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers.Crossref | GoogleScholarGoogle Scholar | 11296145PubMed |
[26] Chandeying V, Garland SM, Tabrizi SN. Prevalence and typing of human papilloma virus (HPV) among female sex workers and outpatient women in southern Thailand. Sex Health 2006; 3 11–4.
| Prevalence and typing of human papilloma virus (HPV) among female sex workers and outpatient women in southern Thailand.Crossref | GoogleScholarGoogle Scholar | 16607969PubMed |
[27] Hernandez BY, Vu Nguyen T. Cervical human papillomavirus infection among female sex workers in southern Vietnam. Infect Agent Cancer 2008; 3 7
| Cervical human papillomavirus infection among female sex workers in southern Vietnam.Crossref | GoogleScholarGoogle Scholar | 18433504PubMed |
[28] Chan R, Khoo L, Ho TH, Koh CF, Lee IW, Yam KL, et al A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J STD AIDS 2001; 12 159–63.
| A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore.Crossref | GoogleScholarGoogle Scholar | 11231868PubMed |
[29] Ford K, Reed BD, Wirawan DN, Muliawan P, Sutarga M, Gregoire L. The Bali STD/AIDS study: human papillomavirus infection among female sex workers. Int J STD AIDS 2003; 14 681–7.
| The Bali STD/AIDS study: human papillomavirus infection among female sex workers.Crossref | GoogleScholarGoogle Scholar | 14596772PubMed |
[30] Miyashita M, Agdamag DM, Sasagawa T, Matsushita K, Salud LM, Salud CO, et al High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. J Med Virol 2009; 81 545–51.
| High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines.Crossref | GoogleScholarGoogle Scholar | 19152419PubMed |
[31] Chatterjee R, Mukhopadhyay D, Murmu N, Jana S. Prevalence of human papillomavirus infection among prostitutes in Calcutta. J Environ Pathol Toxicol Oncol 2001; 20 113–7.
| 11394709PubMed |
[32] Sarkar K, Bhattacharya S, Bhattacharyya S, Chatterjee S, Mallick AH, Chakraborti S, et al Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India. J Infect Public Health. 2008; 1 121–8.
| Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.Crossref | GoogleScholarGoogle Scholar | 20701853PubMed |
[33] Cox JT. Epidemiology and natural history of HPV. J Fam Pract 2006; 3–9.
| 17366752PubMed |
[34] Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008; 18 71–9.
| Human papillomavirus type distribution in women from Asia: a meta-analysis.Crossref | GoogleScholarGoogle Scholar | 17466054PubMed |
[35] Marais DJ, Carrara H, Ramjee G, Kay P, Williamson AL. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers. J Med Virol 2009; 81 203–10.
| HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.Crossref | GoogleScholarGoogle Scholar | 19107974PubMed |
[36] de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7 453–9.
| Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.Crossref | GoogleScholarGoogle Scholar | 17597569PubMed |
[37] Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366 991–8.
| Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.Crossref | GoogleScholarGoogle Scholar | 16168781PubMed |
[38] Ponten J, Guo Z. Precancer of the human cervix. Cancer Surv 1998; 32 201–29.
| 10489629PubMed |
[39] Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, et al Recommendations for cervical cancer prevention in Asia Pacific. Vaccine 2008; 26 M89–98.
| Recommendations for cervical cancer prevention in Asia Pacific.Crossref | GoogleScholarGoogle Scholar | 18945418PubMed |
[40] Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006; 367 1247–55.
| Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.Crossref | GoogleScholarGoogle Scholar | 16631880PubMed |
[41] Future II study group Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356 1915–27.
| Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.Crossref | GoogleScholarGoogle Scholar | 17494925PubMed |
